Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Androgen receptor function links human sexual dimorphism to DNA methylation.

Ammerpohl O, Bens S, Appari M, Werner R, Korn B, Drop SL, Verheijen F, van der Zwan Y, Bunch T, Hughes I, Cools M, Riepe FG, Hiort O, Siebert R, Holterhus PM.

PLoS One. 2013 Sep 4;8(9):e73288. doi: 10.1371/journal.pone.0073288. eCollection 2013.

3.

Molecular basis of androgen insensitivity.

Brinkmann AO.

Mol Cell Endocrinol. 2001 Jun 20;179(1-2):105-9. Review.

PMID:
11420135
4.

Androgen receptor mutations are associated with altered epigenomic programming as evidenced by HOXA5 methylation.

Bens S, Ammerpohl O, Martin-Subero JI, Appari M, Richter J, Hiort O, Werner R, Riepe FG, Siebert R, Holterhus PM.

Sex Dev. 2011;5(2):70-6. doi: 10.1159/000323807. Epub 2011 Feb 11.

5.

Androgen receptor mutations and androgen insensitivity.

McPhaul MJ.

Mol Cell Endocrinol. 2002 Dec 30;198(1-2):61-7. Review.

PMID:
12573815
6.

Reduced expression and normal nucleotide sequence of androgen receptor gene coding and promoter regions in a family with partial androgen insensitivity syndrome.

Choong CS, Sturm MJ, Strophair JA, McCulloch RK, Hurley DM.

Clin Endocrinol (Oxf). 1997 Mar;46(3):281-8.

PMID:
9156036
7.

Physiology and pathophysiology of androgen action.

Hiort O, Holterhus PM, Nitsche EM.

Baillieres Clin Endocrinol Metab. 1998 Apr;12(1):115-32. Review.

PMID:
9890064
8.

Rapid detection of a mutation hot-spot in the human androgen receptor.

Malmgren H, Gustavsson J, Tuvemo T, Dahl N.

Clin Genet. 1996 Oct;50(4):202-5.

PMID:
9001799
9.

Cultured human skin fibroblasts: a model for the study of androgen action.

Brown TR, Migeon CJ.

Mol Cell Biochem. 1981 Apr 13;36(1):3-22. Review.

PMID:
7017379
10.

Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome.

Tincello DG, Saunders PT, Hodgins MB, Simpson NB, Edwards CR, Hargreaves TB, Wu FC.

Clin Endocrinol (Oxf). 1997 Apr;46(4):497-506.

PMID:
9196614
11.

Impact of the genome on the epigenome is manifested in DNA methylation patterns of imprinted regions in monozygotic and dizygotic twins.

Coolen MW, Statham AL, Qu W, Campbell MJ, Henders AK, Montgomery GW, Martin NG, Clark SJ.

PLoS One. 2011;6(10):e25590. doi: 10.1371/journal.pone.0025590. Epub 2011 Oct 3.

12.

Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.

Weidemann W, Linck B, Haupt H, Mentrup B, Romalo G, Stockklauser K, Brinkmann AO, Schweikert HU, Spindler KD.

Clin Endocrinol (Oxf). 1996 Dec;45(6):733-9.

PMID:
9039340
13.

Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.

Quigley CA, Tan JA, He B, Zhou ZX, Mebarki F, Morel Y, Forest MG, Chatelain P, Ritzén EM, French FS, Wilson EM.

Mech Ageing Dev. 2004 Oct-Nov;125(10-11):683-95.

PMID:
15541764
14.

Molecular basis of androgen insensitivity.

Brüggenwirth HT, Boehmer AL, Verleun-Mooijman MC, Hoogenboezem T, Kleijer WJ, Otten BJ, Trapman J, Brinkmann AO.

J Steroid Biochem Mol Biol. 1996 Aug;58(5-6):569-75.

PMID:
8918984
15.

Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.

Jarrard DF, Kinoshita H, Shi Y, Sandefur C, Hoff D, Meisner LF, Chang C, Herman JG, Isaacs WB, Nassif N.

Cancer Res. 1998 Dec 1;58(23):5310-4.

16.

Androgen receptor binding studies on heterozygotes in a family with androgen insensitivity syndrome.

MacLean HE, Chu S, Joske F, Warne GL, Zajac JD.

Biochem Mol Med. 1995 Jun;55(1):31-7.

PMID:
7551823
17.

Intrinsic androgen-dependent gene expression patterns revealed by comparison of genital fibroblasts from normal males and individuals with complete and partial androgen insensitivity syndrome.

Holterhus PM, Deppe U, Werner R, Richter-Unruh A, Bebermeier JH, Wünsch L, Krege S, Schweikert HU, Demeter J, Riepe F, Hiort O, Brooks JD.

BMC Genomics. 2007 Oct 18;8:376.

18.

Clinical and molecular aspects of androgen insensitivity.

Hiort O.

Endocr Dev. 2013;24:33-40. doi: 10.1159/000342499. Epub 2013 Feb 1. Review.

PMID:
23392093
19.
20.

Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome.

Appari M, Werner R, Wünsch L, Cario G, Demeter J, Hiort O, Riepe F, Brooks JD, Holterhus PM.

J Mol Med (Berl). 2009 Jun;87(6):623-32. doi: 10.1007/s00109-009-0462-3. Epub 2009 Mar 30.

Supplemental Content

Support Center